Categories: ActiveTechnology
Innervace is a regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury. Our lead program mimics the lost nigrostriatal pathway in patients with Parkinson’s disease (PD).
Active Portfolio Company
https://www.innervace.com/
Investors 2
Funding Rounds 1
Date | Series | Amount | Investors |
08.09.2022 | Series A | $40M | - |
Mentions in press and media 2
Reviews 0